Location [1]
Chromatin remodeling/DNA methylation
Protein [2]
Histone-lysine N-methyltransferase EZH2
Synonyms [1]

Enhancer of zeste 2 polycomb repressive complex 2 subunit (EZH2) is a gene that encodes the histone-lysine N-methyltransferase EZH2 protein. EZH2 is a member of the polycomb-group family. Members of this family suppress transcription of genes and are involved in embryonic development and cellular differentiation (Gene 2014Genetics Home Reference 2014). EZH2 mutations have been observed in myelodysplastic syndromes, lymphoma, colorectal cancer, and endometrial cancer. In MDS, these mutations often involve deletions or translocations which are believed to be associated with loss of function. Paradoxically, mutations in lymphomas and epithelial neoplasms are thought to involve gain of function.​

EZH2 is altered in 1.52% of all cancers with lung adenocarcinoma, colon adenocarcinoma, cutaneous melanoma, follicular lymphoma, and endometrial endometrioid adenocarcinoma having the greatest prevalence of alterations [3].

EZH2 GENIE Cases - Top Diseases

The most common alterations in EZH2 are EZH2 Mutation (1.20%), EZH2 c.1864-c.2195 Missense (0.44%), EZH2 Exon 16 Mutation (0.26%), EZH2 Codon 641 Missense (0.22%), and EZH2 Nonsense (0.13%) [3].

EZH2 GENIE Cases - Top Alterations

Biomarker-Directed Therapies

Significance of EZH2 in Diseases

Follicular Lymphoma +

Malignant Solid Tumor +

Myelodysplastic Syndromes +

Acute Myeloid Leukemia +

Diffuse Large B-Cell Lymphoma +

Chronic Myelomonocytic Leukemia +

Non-Hodgkin Lymphoma +

Secondary Acute Myeloid Leukemia +

Melanoma +

Multiple Myeloma +

B-Cell Non-Hodgkin Lymphoma +

Lymphoma +

Therapy-Related Acute Myeloid Leukemia +

Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable +

Myelofibrosis +

Myelodysplastic/Myeloproliferative Neoplasm +

Therapy-Related Myelodysplastic Syndrome +

Myelodysplastic Syndrome With Excess Blasts-2 +

Myeloid Neoplasm +

Anaplastic Astrocytoma +

Malignant Peripheral Nerve Sheath Tumor +

Bladder Carcinoma +

Colorectal Carcinoma +

Glioblastoma +

Head And Neck Carcinoma +

Histiocytic And Dendritic Cell Neoplasm +

Non-Small Cell Lung Carcinoma +

Ovarian Carcinoma +

Breast Carcinoma +

Sarcoma +

Pancreatic Carcinoma +

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome +

Epithelioid Sarcoma +

Plasma Cell Leukemia +

Rhabdoid Tumor +

Synovial Sarcoma +


1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.